Cigna Corp (NYSE:CI) Shares Acquired by Tealwood Asset Management Inc.
Tealwood Asset Management Inc. lifted its stake in shares of Cigna Corp (NYSE:CI) by 3.7% in the second quarter, Holdings Channel reports. The institutional investor owned 11,230 shares of the health services provider’s stock after buying an additional 402 shares during the quarter. Tealwood Asset Management Inc.’s holdings in Cigna were worth $1,769,000 as of its most recent SEC filing.
Other hedge funds also recently added to or reduced their stakes in the company. C J Advisory Inc acquired a new position in shares of Cigna during the first quarter valued at $40,000. TRUE Private Wealth Advisors acquired a new position in shares of Cigna during the second quarter valued at $40,000. Trustcore Financial Services LLC acquired a new position in shares of Cigna during the first quarter valued at $49,000. Baldwin Brothers Inc. MA acquired a new position in shares of Cigna during the first quarter valued at $50,000. Finally, Close Asset Management Ltd acquired a new position in shares of Cigna during the first quarter valued at $55,000. 87.64% of the stock is owned by institutional investors and hedge funds.
Shares of NYSE CI traded down $4.13 during midday trading on Thursday, reaching $158.21. 39,882 shares of the company traded hands, compared to its average volume of 1,877,676. Cigna Corp has a 52 week low of $141.95 and a 52 week high of $226.60. The stock has a 50-day moving average price of $168.05 and a 200 day moving average price of $165.49. The company has a debt-to-equity ratio of 0.84, a current ratio of 0.70 and a quick ratio of 0.70. The company has a market cap of $61.54 billion, a price-to-earnings ratio of 11.12, a PEG ratio of 0.83 and a beta of 0.70.
Several equities analysts have recently issued reports on CI shares. Morgan Stanley reduced their price target on shares of Cigna from $241.00 to $207.00 and set an “overweight” rating for the company in a report on Friday, July 12th. Zacks Investment Research cut shares of Cigna from a “buy” rating to a “hold” rating and set a $164.00 price objective on the stock. in a research note on Tuesday, June 11th. Citigroup cut their price objective on shares of Cigna from $228.00 to $203.00 and set a “buy” rating on the stock in a research note on Monday, June 3rd. Goldman Sachs Group cut shares of Cigna from a “conviction-buy” rating to a “buy” rating in a research note on Friday, May 3rd. Finally, Raymond James lifted their price objective on shares of Cigna from $185.00 to $190.00 and gave the company an “outperform” rating in a research note on Friday, August 2nd. One analyst has rated the stock with a sell rating, three have given a hold rating and fourteen have assigned a buy rating to the stock. Cigna currently has a consensus rating of “Buy” and a consensus price target of $214.55.
Cigna Company Profile
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
See Also: Different Options Trading Strategies
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corp (NYSE:CI).
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.